Navigation Links
The Coming of Biotech Generic Pharmaceuticals

CHICAGO In a column last year, I commented on the growing generic pharmaceuticals business in the U.S. and around the world. Generic pharmaceuticals are not only big business but will continue to get even bigger. There are a couple reasons why:

1) Numerous drug patents expiring over the next couple years.

2) The increased concern in the U.S. about rising drug pri......

Full article >>> s).

Second, the actual final manufacturing isnt easy and requires special care. Most of these products are injectables as few if any protein-based drugs can be administered orally. They do not successfully survive the transition through the stomach in order to release a therapeutic effect in the gastrointestinal tract.

So what is at stake here? The answer is a lot! Biotech drug......

Full article >>> t, most cancers are still incurable and only a few types of cancer (testicular cancer and some types of leukemias) are curable. Existing therapy only has marginal effect. There is plenty of room here for therapeutic improvement particularly considering there are more than 1 million new cases of cancer in the U.S. alone each year.

2) The FDA has recognized this dilemma and has prov......

Full article >>>

Unfortunately, the NCI today is a very large bureaucracy whose goal is the discovery and development of new therapies but not the commercialization of such therapy. As such, the NCI process is very slow.



Given the NCIs role in developing and funding the early stage development of many cancer drugs and the governments concern about the rising cost of medicines, it is ......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 01/26/04


Related biology technology :

1. Social engineering - Coming to an IT ship near you?
2. Biotech officials praise focus of new venture fund
3. Biotech executive books a career flight thats closer to home
4. Gala Biotech among companies sold for $3.3 billion
5. Biotech with Madison ties raises $21M in capital
6. Biotech firm uses live heart tissue in drug screens
7. Biotech talent drew venture-funded firm to Madison
8. Biotech firm has strokes, Alzheimers in its sights
9. 42 days until the 2006 Olympics of Biotechnology in Chicago
10. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
11. Biotech leads list of top U.S. companies to work for
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... ... May 24, 2017 , ... ... as treasurer for the Mid-Atlantic chapter of the Healthcare Businesswomen’s Association ... , The HBA Mid-Atlantic chapter board meets in person once each quarter and ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... systems are increasingly being developed with Wi-Fi connectivity to reduce the amount of ... room to room. In addition, compact mobile devices including infusion pumps, heart and ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... source of human cardiovascular cells for research and the development of cardiac ... possible to generate large numbers of cardiomyocytes (hPSC-CMs). Due to varying differentiation ...
(Date:5/23/2017)... ... , ... Vortex Biosciences , provider of circulating tumor cell (CTC) capture ... using Vortex microfluidic technology ” in Nature Precision Oncology on May 8th. The ... and Dr. Matthew Rettig at the University of California, Los Angeles. The publication describes ...
Breaking Biology Technology:
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):